Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells

BACKGROUND: Our previous studies showed that the non-psychoactive cannabinoid, cannabidiol (CBD), ameliorates the clinical symptoms in mouse myelin oligodendrocyte glycoprotein (MOG)35-55-induced experimental autoimmune encephalomyelitis model of multiple sclerosis (MS) as well as decreases the memo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neuroinflammation
Autori principali: Kozela, Ewa, Juknat, Ana, Gao, Fuying, Kaushansky, Nathali, Coppola, Giovanni, Vogel, Zvi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891926/
https://ncbi.nlm.nih.gov/pubmed/27256343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-016-0603-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi